Pfizer’s COVID-19 vaccine is just as effective against the Omicron variant

Invezz

Published

The preliminary data from lab studies shows Pfizer Inc’s (NYSE: PFE) COVID-19 vaccine that it developed in collaboration with Germany’s BioNTech is just as effective against the new, heavily mutated variant of the Coronavirus. Omicron can’t escape a booster shot In an announcement on Wednesday, the pharmaceutical giant said a booster dose of its vaccine […]

Full Article